Opus Genetics IRD Federal Operating Loss Carryforwards Tax Effect
Federal Operating Loss Carryforwards Tax Effect at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept ird:FederalOperatingLossCarryforwardsTaxEffect.
The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's federal operating loss carryforwards tax effect.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's federal operating loss carryforwards tax effect?
- Opus Genetics (IRD) reported federal operating loss carryforwards tax effect of $0 in Q4 2025.
- What is the long-term trend for Opus Genetics's federal operating loss carryforwards tax effect?
- Over 2 years (2023 to 2025), Opus Genetics's federal operating loss carryforwards tax effect has grown at a -100.0% compound annual growth rate (CAGR), from $200K to $0.
- What does federal operating loss carryforwards tax effect mean?
- This metric quantifies the potential tax savings from federal net operating losses that are available to offset future federal taxable income. For companies in the development stage, this represents a significant deferred tax asset that may provide future liquidity by reducing cash tax payments. It is a key component in evaluating the long-term tax efficiency of the corporate structure.